• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.40 Up 0.01(0.72%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:1.39
    Open:1.40
    Bid:N/A
    Ask:2.61 x 1000
    1y Target Est:4.17
    Beta:-0.16
    Earnings Date:Mar 5 - Mar 9 (Est.)
    Day's Range:1.38 - 1.40
    52wk Range:1.27 - 3.18
    Volume:212,842
    Avg Vol (3m):972,544
    Market Cap:254.91M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PPHM

    Comparison

    Symbol% ChgMkt Cap
    PPHMUp 0.72%254.91M
    AMGNUp 2.00%122.22B
    NVSUp 0.71%227.14B
    RHHBYDown 0.03%232.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-15) :-0.28
    Quarterly EPS Est (Jan-15) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback